Valuation: AstraZeneca PLC

Market Cap 241B 1,259B 208B 196B 178B 334B 22,977B 340B 2,292B 896B 11,517B 904B 884B 38,375B P/E 2026 *
19.9x
P/E 2027 * 17.3x
Enterprise Value 260B 1,360B 225B 212B 192B 361B 24,821B 367B 2,475B 968B 12,441B 976B 955B 41,455B EV / Sales 2026 *
4.11x
EV / Sales 2027 * 3.78x
Free-Float
96.63%
Yield 2026 *
2.14%
Yield 2027 * 2.27%
1 day+0.20%
1 week-0.25%
Current month-5.26%
1 month-4.45%
3 months-10.97%
6 months-24.12%
Current year-19.23%
1 week 133.75
Extreme 133.75
138.2
1 month 130.06
Extreme 130.06
149.01
Current year 130.06
Extreme 130.06
190.4
1 year 130.02
Extreme 130.02
190.4
3 years 101.6
Extreme 101.6
190.4
5 years 93.74
Extreme 93.74
190.4
10 years 93.74
Extreme 93.74
190.4
Manager TitleAgeSince
Chief Executive Officer 66 2012-09-30
Director of Finance/CFO 52 2021-07-31
Compliance Officer - 2022-12-31
Director TitleAgeSince
Director/Board Member 70 1999-04-05
Director/Board Member 66 2012-09-30
Director/Board Member 65 2017-04-26
Change 5-day change 1-year change 3-year change Capi.($)
+0.20%-0.25% - - 241B
-2.25%-0.47%+68.30%+115.90% 1,052B
-0.66%+0.43%+47.39%+50.54% 627B
-0.54%+1.39%+20.69%+63.99% 441B
-1.99%-3.32%+38.71%+35.41% 349B
-1.05%-2.81%+23.07%+35.70% 287B
-2.12%-3.67%-1.14%+5.37% 241B
-0.63%+1.04%+40.05%+56.09% 224B
-1.19%-3.41%-9.57%-52.71% 202B
+0.16%+3.87%+16.89%+73.73% 172B
Average -1.01%+0.43%+27.15%+42.67% 399.46B
Weighted average by Cap. -1.26%+0.32%+39.09%+61.29%

Financials

2026 *2027 *
Net sales 63.25B 331B 54.68B 51.44B 46.74B 87.76B 6,035B 89.3B 602B 235B 3,025B 237B 232B 10,080B 66.85B 349B 57.8B 54.37B 49.4B 92.75B 6,379B 94.39B 636B 249B 3,197B 251B 246B 10,654B
Net income 12.07B 63.08B 10.43B 9.82B 8.92B 16.75B 1,152B 17.04B 115B 44.9B 577B 45.3B 44.33B 1,923B 13.72B 71.68B 11.86B 11.15B 10.13B 19.03B 1,309B 19.36B 131B 51.02B 656B 51.47B 50.37B 2,186B
Net Debt 19.33B 101B 16.71B 15.72B 14.28B 26.81B 1,844B 27.29B 184B 71.89B 924B 72.53B 70.98B 3,080B 11.66B 60.93B 10.08B 9.48B 8.61B 16.18B 1,112B 16.46B 111B 43.37B 558B 43.75B 42.82B 1,858B
Logo AstraZeneca PLC
AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows: - product sales (99.8%). Net sales break down by treatment area between oncology (42.6%), cardiovascular, renal and metabolic diseases (23%), respiratory and autoimmune diseases (14.7%), and other (19.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases); - collaboration revenue (0.2). Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (22.9%), the United States (40.8%), Americas (6.1%) and Africa/Asia/Australia (22.8%).
Employees
96,100
Date Price Change Volume
26-08-14 R$136.22 +0.17% 864
26-08-13 R$135.99 +0.03% 104
26-08-12 R$135.95 -0.23% 1,065
26-08-11 R$136.26 -1.00% 65
26-08-10 R$137.63 +0.78% 48
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
155.26USD
Average target price
211.68USD
Spread / Average Target
+36.34%

Quarterly revenue - Rate of surprise